<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0014">
 <label>14.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Qiu</surname>
   <given-names>P</given-names>
  </string-name>, 
  <string-name>
   <surname>Cui</surname>
   <given-names>X</given-names>
  </string-name>, 
  <string-name>
   <surname>Barochia</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Li</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Natanson</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Eichacker</surname>
   <given-names>PQ</given-names>
  </string-name>. 
  <article-title>The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death</article-title>. 
  <source>
   <italic toggle="yes">Expert Opin Investig Drugs</italic>
  </source>. 
  <year>2011</year>;
  <volume>20</volume>(
  <issue>11</issue>):
  <fpage>1555</fpage>â€“
  <lpage>1564</lpage>. doi:
  <pub-id pub-id-type="doi">10.1517/13543784.2011.623125</pub-id>
 </mixed-citation>
</ref>
